ImmunoPrecise Announces Data from Preclinical Study of TATX-03 PolyTope™ Monoclonal Antibody Cocktail Candidate Against COVID-19. Visit our website to learn more: https://t.co/DDkNOPopfM $IPA
#Covid19#antibody#preclinical#innovation
$IPA $IPA.v @ImmunoPrecise the Biopharma world is just beginning to understand the power of our platforms to discover New #Antibody drugs to solve various disease states 💯 It’s our scientific🧬 secret sauce 🔜🥊🦠
@MagicienDeRiga @WSBChairman Let little $Ipa ( David) slingshot upto the Goliath’s ( nvax, JNJ, pfe etc) . Results of pre clinicals anyday now on PolyTope 4 antibody Covid cocktail
$Ipa -Nasdaq Immunoprecise Antibodies Ltd . Huge institution accumulating. Numbers are as of Dec.31 . Wow 2.35% of the entire company. INGALLS and Snyder . Nearly 400k @LuoshengPeng
$CHM $CHM.C Beauty of a breakout on strong volume, reaching the first technical target. Still undervalued given the magnitude of today's news at below $7M mkt cap, IMO.
I wrote this earlier today
To achieve a multi-bagger in the portfolio, you have to hold a multi-bagger in the portfolio. Holding can be excruciating. Especially winners.
https://t.co/OfGE2jIGGv
This is a tremendous opportunity to push the science further as this antibody-based nanomedicine format is hypothesized to have additional therapeutic benefits compared to single monoclonal antibody equivalents https://t.co/zFVVVIXfzS